Literature DB >> 4795224

Augmentation of chemotherapeutically induced remission of a murine leukemia by a chemical immunoadjuvant.

M A Chirigos, J W Pearson, J Pryor.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4795224

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  15 in total

1.  Augmentation of the in vitro mitogenic response of owl monkey peripheral blood lymphocytes by levamisole and loss of this effect with the development of herpesvirus saimiri-induced lymphoma.

Authors:  R H Neubauer; H Rabin
Journal:  Clin Exp Immunol       Date:  1978-07       Impact factor: 4.330

2.  Letter: Treatment of recurrent aphthous stomatitis and herpes with levamisole.

Authors:  J Symoens; J Brugmans
Journal:  Br Med J       Date:  1974-12-07

3.  Immunopotentiation with levamisole in resectable bronchogenic carcinoma: a double-blind controlled trial; Study Group for Bronchogenic Carcinoma.

Authors: 
Journal:  Br Med J       Date:  1975-08-23

4.  Levamisole maintains cyclophsophamide-induced remission in murine lupus erythematosus.

Authors:  J Zulman; J Michalski; C McCombs; J Greenspan; N Talal
Journal:  Clin Exp Immunol       Date:  1978-02       Impact factor: 4.330

5.  Restoration by levamisole of immune responses suppressed in tumor-bearing mice.

Authors:  M Shiraishi; K Himeno; K Nomoto
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

6.  In vitro stimulation of murine lymphoid cell cultures by levamisole.

Authors:  V J Merluzzi; A M Badger; C W Kaiser; S R Cooperband
Journal:  Clin Exp Immunol       Date:  1975-12       Impact factor: 4.330

7.  Immunotherapy of cancer.

Authors:  E C Holmes; D L Morton; F R Eilber
Journal:  West J Med       Date:  1977-02

8.  In vitro reversal of cellular unresponsiveness induced by levamisole.

Authors:  H Golding; B Golding; R Jacobson; R Lomnitzer; H J Koornhof; A R Rabson
Journal:  Clin Exp Immunol       Date:  1976-11       Impact factor: 4.330

9.  Potentiation of T-cell mediated immunity by levamisole.

Authors:  G Renoux; M Renoux; M N Teller; S McMahon; J M Guillaumin
Journal:  Clin Exp Immunol       Date:  1976-08       Impact factor: 4.330

10.  Levamisole augments the cytotoxic T-cell response depending on the dose of drugs and antigen administered.

Authors:  R B Faanes; P Dillon; Y S Choi
Journal:  Clin Exp Immunol       Date:  1977-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.